BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7450403)

  • 1. Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma.
    Broder S; Callihan TR; Jaffe ES; DeVita VT; Strober W; Bartter FC; Waldmann TA
    Gastroenterology; 1981 Jan; 80(1):166-8. PubMed ID: 7450403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-losing enteropathy in systemic lupus erythematosus associated with intestinal lymphangiectasia.
    Edworthy SM; Fritzler MJ; Kelly JK; McHattie JD; Shaffer EA
    Am J Gastroenterol; 1990 Oct; 85(10):1398-402. PubMed ID: 2220736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal lymphangiectasia in systemic lupus erythematosus.
    Pereira AS; Pereira Filho RA; Trevisan MA; Magalhães AF
    Arq Gastroenterol; 1980; 17(4):210-2. PubMed ID: 7247748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-Hodgkin lymphoma arising in a case of Waldmann's intestinal lymphangiectasis].
    Herait P; Gisselbrecht C; Ferme C; Jian R; Modigliani R; Griscelli C; Hervio P; Marty M; Boiron M
    Nouv Rev Fr Hematol (1978); 1985; 27(5):299-302. PubMed ID: 4080538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of malabsorption in congenital intestinal lymphangiectasia following chemotherapy for lymphoma.
    Shpilberg O; Shimon I; Bujanover Y; Ben-Bassat I
    Leuk Lymphoma; 1993 Sep; 11(1-2):147-8. PubMed ID: 8220148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal lymphangiectasis secondary to cicatricial fibrosis of mesenteric nodes: a nosologic entity?].
    Molas G; Ponsot P; Amouyal P; Vallin J; Vitaux J; Paolaggi JA; Potet F
    Gastroenterol Clin Biol; 1990; 14(12):1010-4. PubMed ID: 2289659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal lymphangiectasia in systemic sclerosis.
    van Tilburg AJ; van Blankenstein M; Verschoor L
    Am J Gastroenterol; 1988 Dec; 83(12):1418-9. PubMed ID: 3195550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of protein-losing enteropathy after nodal lymphoma treatment in a patient with primary intestinal lymphangiectasia.
    Laharie D; Degenne V; Laharie H; Cazorla S; Belleannee G; Couzigou P; Amouretti M
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1417-9. PubMed ID: 16292099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N; Ishibashi K; Uno H; Hino N
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary intestinal lymphangiectasis. Apropos of a clinical case].
    Cervini M; Ghiringhelli P
    Minerva Med; 1985 Nov; 76(44):2143-51. PubMed ID: 4069427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-losing enteropathy in systemic lupus erythematosus.
    Takagi S; Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
    Am J Gastroenterol; 1983 Mar; 78(3):152-4. PubMed ID: 6829533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-losing enteropathy secondary to intestinal lymphangiectasia in a dog.
    Olson NC; Zimmer JF
    J Am Vet Med Assoc; 1978 Aug; 173(3):271-4. PubMed ID: 689969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia.
    Pratz KW; Dingli D; Smyrk TC; Lust JA
    Medicine (Baltimore); 2007 Jul; 86(4):210-214. PubMed ID: 17632262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia.
    Chamouard P; Nehme-Schuster H; Simler JM; Finck G; Baumann R; Pasquali JL
    Dig Liver Dis; 2006 Sep; 38(9):699-703. PubMed ID: 16527553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmental dilatation of the ileum accompanying hypoproteinemia.
    Elemen L; Inanc D; Oz F; Erdogan E
    J Pediatr Surg; 2008 Jul; 43(7):e15-8. PubMed ID: 18639668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hemolytic uremic syndrome associated with intestinal lymphangiectasia.
    Kalman S; Bakkaloğlu S; Dalgiç B; Ozkaya O; Söylemezoğlu O; Buyan N
    J Nephrol; 2007; 20(2):246-9. PubMed ID: 17514630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic consideration of protein-losing enteropathy due to lymphangiectasia of the intestine.
    Iida F; Wada R; Sato A; Yamada T
    Surg Gynecol Obstet; 1980 Sep; 151(3):391-5. PubMed ID: 7404312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.